Financials / Press Releases

INVESTOR RELATIONS

BIOQUAL, Inc. is a public company traded on the OTC Markets Group – Symbol BIOQ.

BIOQUAL, Inc.’s Transfer Agent:

Computershare, Inc.
480 Washington Boulevard
Jersey City, New Jersey 07310
www.computershare.com

CONTACT:

Mark Lewis
President / Chief Executive Officer
BIOQUAL, Inc.
Phone: (240) 404-7654 ext. 1012

Press Release, 03/31/20, BIOQUAL Announces COVID-19 Vaccine Testing

BIOQUAL Presents Financial Results for FY 2020 Second Quarter Ending November 30, 2019 [Updated 01/21/20]

Press Release, 01/21/20, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Second Quarter of Fiscal Year 2020 [Updated 01/22/19]

BIOQUAL Presents Unaudited Financial Statements and Management’s Discussion and Analysis for First Quarter of Fiscal Year 2020 Ending August 31, 2019 [Updated 10/21/19]

Press Release, 10/21/19, BIOQUAL, Inc. and Subsidiary Presents Unaudited Financial Results for First Quarter of Fiscal Year 2020

Mark Lewis Letter To Shareholders [09/20/19]

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2019 [Updated 09/13/19]

BIOQUAL, Inc. and Subsidiary Presents Audited Consolidated Financial Statements for Fiscal Year 2019 [Updated 09/13/19]

Press Release, 09/13/19, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2019 and Declares Dividend

BIOQUAL Presents Unaudited Financial Results for FY 2019 Third Quarter Ending February 28, 2019 [Updated 04/16/19

Press Release, BIOQUAL, Inc. Presents Financial Results for FY 2019 Third Quarter [Updated 04/16/19]

In Memoriam, J. Thomas August, M.D. [Updated 02/22/19]

Press Release, 02/22/19, Death of J. Thomas August, M.D., a Member of the Board of Directors of BIOQUAL, Inc.

Mark Lewis Letter To Shareholders [10/18/18]

Press Release, 09/11/18, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2018 and Declares Dividend

BIOQUAL, Inc. and Subsidiary Presents Audited Financial Statements ending May 31, 2018 and 2017 [Updated 09/11/18]

Management’s Discussion and Analysis for the Fiscal Year ended 05/31/2018 [Updated 09/11/18]

Bioqual Announces Appointment of Dr. Vivek Patil to Board and Announces Results from 2018 Meeting of Stockholders [09/11/18]

Mark Lewis Letter To Shareholders [09/27/17]

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2017 [Updated 09/27/17]

BIOQUAL Presents Audited Financial Statements for Years Ended May 31, 2017 and 2016 [Updated 09/07/17]

Press Release, BIOQUAL, Inc. Presents Financial Results for FY 2017 and Declares Dividend [Updated 09/07/17]

Please send mail to itdept@bioqual.com with questions or comments about this website.